ARCHIVES

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

This article is from The Cancer Letter archive.

Vol. 33 No. 45 | December 7, 2007

Download PDF Visit The Full Archive

Related Articles

NCI Awards 12 Grants For Planning of New Cancer Centers

March 27, 1992

GAO Backs DeVita On Why advances Aren’t Producing Mortality Reduction

February 5, 1988

Top Officials Resign From San Antonio’s Institute for Drug Development.

January 26, 2007

NCAB Meeting Moved To October

July 20, 1979

Blazing the Pathways: Informatics Platform Provides Foundation for “Center Without Walls”

January 11, 2013

Hammer Gives $100,000 to Expand Rosenberg’s T-Cell Growth Factor Clinical Studies

March 1, 1985